CC BY
16
UDC 57.017.22 https://doi.org/10.15407/biotech11.02.072
PECULIARITIES OF ANTIBIOTIC BATUMIN ACTION ON BIOFILM FORMATION BY Staphylococcus aureus
AND Pseudomonas batumici
1Zabolotny Institute of Microbiology and Virology of the National Academy of Sciences of Ukraine, Kyiv
2Institute of Orthopedics and Traumatology of the National Academy of Medical Sciences of Ukraine, Kyiv
E-mail: [email protected]
Received 11.01.2018
The aim of the work was the research of antibiotic batumin action on the biofilm formed by staphylococci and on the process of the biofilm formation by strain-producer Pseudomonas batumici. The minimal inhibiting concentration (MIC) of batumin was studied according to The Clinical and Laboratory Standards Institute standards — CLSI. Biofilm formation was studied using photometric O'Toole method with flatbed photometer at wavelength 540 nm. The batumin penetrated into biofilms of staphylococci and reduced the biomass of the formed biofilm of Staphylococcus aureus and S. epidermidis at the antibiotic concentration of 0.5 pg/ml, which was only twice higher than MIC of batumin for planktonic cells. The degree of biofilm changes in the presence of batumin differed for different staphylococcus strains. However, these differences did not depend on strains sensitivity or their resistance to the antibiotic.
The ability of batumin strain-producer to form the biofilm and the ability of antibiotic to stimulate this process in concentrations of 1 and 10 pg/ml was established for the first time. In addition, it was found that in the Pseudomonas batumici B-321 planktonic culture in the presence of 10 pg/ml of batumin, the increase in length of producer cells on average by 15% was noted.
The obtained data shed the light on batumin antimicrobic action on the staphylococci biofilm. It can be argued that is a perspective for treatment of staphylococcal infections. It enabled to consider batumin as a promising drug for the staphylococcal infections treatment.
Key words: batumin, staphylococci, biofilm.
L. N. Churkina1 V. V. Klochko1 S. D. Zagorodnya1 L. V. Yaroshenko1 O. B. Luitko2
The polyketide antibiotic batumin synthesized by the producer strain Pseudomonas batumici has a high selective activity against staphylococci [1,2], which determines the prospects for its medical application in the treatment of staphylococcal infections and the control of the nasal carriage of this pathogen [3]. Data obtained in recent years indicate that 95 to 99% of microorganisms in natural habitats exist in the form of biofilms. It is known that bacterial biofilms are involved in the pathogenesis of chronic infections such as osteomyelitis, rhinosinusitis, etc. [4, 5]. At the same time, it is known that bacteria structured in biofilm are more resistant to antibiotics [5], which is one of the problems of successful chemotherapy.
Our preliminary studies on the effect of batumin on biofilm formation in representatives of the genus Staphylococcus showed that the presence in the medium of 0.125 pg/ml of batumin (half of growth inhibiting concentration) significantly reduced the formation of biofilm in 85% of the studied nasal strains of staphylococci with an initially high level of biofilm formation [6]. The use of atomic force electron microscopy showed that the batumin reduced several times the staphylococci adhesion to the surface, thus inhibiting the early stages of biofilm formation [7].
On the other hand, the role of antimicrobial substances for cells of producer strains in nature is far from being exhausted by their antibiotic activity. Strains of P. batumici are isolated from the soil and are rhizosphere
bacteria that interact with plants and compete with different microflora. The formation of biofilm by such bacteria ensures the nutrients exchange with the plant, the synthesis of antimicrobial substances that protect against phytopathogens and many other effects [8].
In connection with the foregoing, the aim of this work was to study the effect of batumin on the biofilm formed by staphylococci, and to study the influence of batumin on the process of biofilm formation by the producer strain P. batumici.
Materials and Methods
The object of the study were 16 strains of Staphylococcus aureus and S. epidermidis, including 5 methicillin-resistant strains (MRSA) isolated at the Institute of Orthopedics and Traumatology of the Academy of Medical Sciences of Ukraine from patients with osteomyelitis. The strains of MRSA are identified by the method suggested by Boutiba-Ben Boubaker [9].
Another object was a typical antibiotic batumin producing strain Pseudomonas batumici UCM B-321 from the Ukrainian Collection of Microorganisms (Zabolotny Institute of Microbiology and Virology of the National Academy of Sciences of Ukraine).
Antibiotic batumin was obtained by fermentation of B. batumici strain UCM B-321 and purified by preparative chromatography (90% purification degree) [10].
The sensitivity of clinical strains of staphylococci to a broad spectrum of antibiotics was determined using the Kirby-Bauer method, CLSI criteria were used to interpret antibiotic sensitivity. Discs impregnated with the appropriate antibiotics were used: amoxiclav, erythromycin, clindamycin, rifampicin, ciprofloxacin, doxycycline, vancomycin, teicoplanin, amikacin, linezolid, lincomycin (Himedia, India). The minimal inhibiting concentration of the batumin was studied in accordance with CLSI standards on Muller-Hinton agar and Muller-Hinton broth [11].
The biofilm formation study was carried out according to the O'Toole method [12]. In studying the activity of batumin against biofilms formed by S. aureus and S. epidermidis cultures, biofilms were grown on the bottom of plastic 96-well plates (Thermo Scientific, USA). 0,2 ml of staphylococci broth culture was introduced into the wells. The initial concentration of cells was 5107 cells/ml, cultivation was carried out for
24 hours at t = 37 °C, further the batumin was added in concentrations of 0.1; 0.5 and 5.0 pg/ml, followed by incubation for 24 hours. After that, the liquid contents of the wells were removed, washed three times with phosphate buffer (pH 7.2), dried and stained. The percentage of biofilm inhibition (BI) was calculated as follows [5]:
BI (%) = 100 - [ ODbatUmin/ODcontr0l],
where ODbatumin is optical density in the holes with the batumin,ODcontrol is optical density in wells without batumin (control).
To study the biofilm formation by P. batumici strain UCM B-321, it was grown at t = 28 °C for 48 h in 96-well plates on Luria-Bertani medium (Becton, USA). 0.25 ml of the cell culture suspension (5107 cells/ml) was introduced into the wells in a nutrient medium, as well as various (1 and 10 pg/ml) concentrations of batumin.
A 0.1% solution of gentian violet ColorGram 2-F (bioMerieux, France) was used as the biofilm dye, and 0.1 ml was added to each culture well. After thirty minutes of contact at room temperature, the dye was washed three times with distilled water and the ink was dissolved with 96% ethyl alcohol. The results were recorded using a Multiskan FC (Thermo Scientific, USA) flatbed photometer at a wavelength of 540 nm.
Results and Discussion
Table 1 shows the results of studying the sensitivity of clinical staphylococcus strains to widely used in medical practice antibiotics.
The obtained data suggest the high resistance of MRSA strains to the studied antibiotics (the growth retardation zones were only 6 mm), which agrees with the literature data [13, 14]. At the same time, all investigated staphylococci strains, including MRSA, regardless of the source of their isolation and sensitivity to different antibiotics, were sensitive to the batumin.
The next stage of our work was to study the ability of clinical isolates of S. aureus and S. epidermidis to form biofilms (Fig. 1).
All studied strains of staphylococci formed a biofilm with different biomass values from 0.20 to 0.68 units of optical density. Strains that did not synthesize biofilm were not detected.
Further, we determined the MIC of the batumin with its action on staphylococcus cells, both in planktonic culture and in the composition of biofilms (Table 2).
Table 1. Sensitivity of clinical Staphylococcus strains to antibiotics
Strains Zones of growth retardation, mm
Amoxiclav Erythromycin Clindamycin Rifampicin Ciprofloxacin Doxycycline Vancomycin Teicoplanin Amikacin Linezolid Lincomycin Batumin
S. aureus 75(MRSA) 6 6 6 18 6 22 19 17 16 6 6 25
S. aureus 76 (MRSA) 6 6 6 6 6 20 18 20 21 6 26 30
S. aureus 77 (MRSA) 6 6 22 6 6 6 17 20 17 6 20 32
S. aureus 1463(MRSA) 6 6 6 25 20 20 16 19 16 24 28 28
S. aureus 1813(MRSA) 6 6 6 6 6 24 18 22 22 25 6 35
S. aureus 80 22 6 20 31 24 28 18 24 22 25 24 26
S. aureus 175 6 18 22 35 26 6 15 18 H 19 30 32
S. aureus 1306 25 10 25 25 28 6 20 18 26 26 26 30
S. aureus 1310 30 16 18 24 22 6 19 22 25 28 22 28
S. aureus 1316 30 30 22 24 6 20 18 22 18 25 22 32
S. aureus 1358 20 26 18 30 6 22 17 22 19 25 20 32
S. aureus 1440 20 6 20 6 30 15 17 18 24 21 28 35
S. aureus 1749 25 28 24 28 30 26 20 20 22 22 25 35
S. epidermidis 151 6 20 28 6 24 17 22 20 22 24 20 30
S. epidermidis 618 6 32 22 22 19 19 20 24 20 20 22 32
S. epidermidis 1803 6 6 26 22 20 17 24 26 25 6 18 28
0,9 0,3 £ 0,7
Fig. 1. Biofilm formation in vitro in strains S. aureus and S. epidermidis
Table 2. The minimal inhibitory concentration of batumin for plankton cells and Staphylococcus biofilms
Strains Batumin concentration, pg/ml
Plankton cells Biofilm
S. aureus 75 (MRSA) 0.25 0.5
S. aureus 76 (MRSA) 0.25 0.5
S. aureus 77 (MRSA) 0.25 0.5
S. aureus 1463 (MRSA) 0.25 0.5
S. aureus 1813(MRSA) 0.25 0.5
S. aureus 80 0.25 0.5
S.aureus 175 0.25 0.5
S.aureus 375 0.25 0.5
S. aureus 1306 0.25 0.1
S. aureus 1310 0.25 0.5
S. aureus 1316 0.25 0.5
S. aureus 1358 0.25 0.5
S. aureus 1440 0.25 0.5
S. aureus 1749 0.25 0.5
S. epidermidis 151 0.25 0.1
S. epidermidis 618 0.25 0.5
S. epidermidis 1803 0.25 0.5
For planktonic staphylococcus cells, the MIC of the batumin was 0.25 pg/ml, the MIC for the biofilms of each studied strain was 0.5 pg/ml, except for the strain of S. aureus 1306 (MIC = 0.1 pg/ml).
In the course of the work, it has been found that in the presence of batumin the significant changes occurred in the biomass of the microbial community of staphylococci in the formed biofilm (Table 3).
From the results obtained, it can be seen that the decrease in the biomass of the formed biofilm depended on the concentration of the antibiotic, and the intensity of the effect was different in the studied strains. Thus, the batumin concentration of 0.5 pg/ ml, which was only twice as high as MIC, caused a decrease in biomass of biofilm from 34.7 to 77.0%. A further increase in the concentration of antibiotic to 5 pg/ml only slightly changed the mass of the biofilm.
According to the literature, the addition of antibiotics such as ampicillin, cefatoxime, levofloxacin, rifampicin in concentrations
50 times higher than MICs causes a decrease in the mass of the formed biofilm up to 30% maximum [15]. Highly active against staphylococci antibiotic mupirocin isolated from bacteria of the genus Pseudomonas, reduced biomass of the formed biofilm by 90% in all investigated isolates of S. aureus at concentrations 250 times higher than MIC [5].
According to Moreno M.G. et al. [16] the MICs of phosphomycin, rifampicin and levofloxacin when they act on plankton cells were 1-16 pg/ml, and on biofilms — more than 1024 pg/ml. The exception was the antibiotic gentamicin, the MIC of which, when it acts on plankton cells was 4-8 pg/ml, on biofilms — 8-16 pg/ml. Allison et al. [17] found that gentamicin kills persistent cells of Escherichia coli and Staphylococcus aureus. Persistent cells are a subpopulation in biofilm and are tolerant to antibiotics, thus remain viable when exposed to pharmaceuticals. The author suggests that rifampicin and benzylpenicillin kill most of the cells in the
Table 3. Batumin effect on formed biofilms biomass of staphylococci
Strains Batumin concentration, pg/ml
0.1 0.5 5.0
S. aureus 75 (MRSA) Decrease in relation to control,%
47.7 57.2 57.4
S. aureus 76 (MRSA) 31.1 34.7 34.1
S. aureus 77 (MRSA) 57.9 63.2 60.3
S. aureus 1463 (MRSA) 67.7 69.3 68. 2
S. aureus 1813 (MRSA) 75.2 77.0 77.0
S. aureus 80 36.0 40.1 40.0
S. aureus 175 39.3 50.0 49.3
S. aureus 375 38.1 52.4 51.0
S. aureus 1306 56.8 56.8 54.0
S. aureus 1310 64.0 74.3 74.2
S. aureus 1316 25.8 37.2 34.3
S. aureus 1358 65.0 67.5 68.5
S. aureus1440 57.2 65.8 62.9
S. aureus 1749 35.0 60.0 60.1
S. epidermidis 151 48.4 51.5 54.8
S. epidermidis 618 40.2 44.1 44.0
S. epidermidis 1803 50.0 60.3 60.0
biofilm, except persisters, and gentamycin, selectively acting, leads to their complete eradication. Earlier, we showed that the batumin also has a high activity against SSCVs persisters (S. aureus small colony variants) [18]. Thus, by the mechanism of action on staphylococcus biofilms the batumin is probably similar to gentamicin.
The obtained results indicate that the batumin penetrates into the formed biofilms of clinical strains of S. aureus and S. epidermidis, and after 24 hours of action causes a decrease in the biofilm formation process. It should also be noted that the antibiotic significantly reduces the biomass of the biofilm formed in strains with an initially high level of biofilm formation (Table 3). We obtained similar results when studying the action of antibiotic batumin on biofilm developing. The efficacy of batumin at a concentration of 0.125 pg/ml (half of its MIC) was higher for strains with a high biofilm weight [6].
It is known that matrix components play an important role in the process of antibiotics
penetration into biofilms. The lipids of the biofilm matrix and bacterial membranes are identical in qualitative composition [19]. When studying the mechanism of batumin action on staphylococci, we found that in this pathogen under the action of antibiotic the significant changes in the fatty acid profile, which leads to an increase in fluidity of membrane lipids and permeability of the membrane in S. aureus take place [20]. Based on the similarity of the composition of the biofilm matrix lipids on one side, and the membrane of the bacterial cell on the other side, it can be assumed that the batumin penetrates well into the biofilm of staphylococci and causes significant changes in the biofilm formed, which we observed.
Attention is drawn to the fact that the intensity of changes in biofilms in the presence of batumin differs in different strains of staphylococci, however, these differences do not depend on the sensitivity or resistance of strains to the studied antibiotics (Tables 1 and 3).
Fig. 2. Batumin effect on the biofilm formation by strain P. batumici UCM В-321:
marked columns (*) are significantly differ from the control at P < 0,05
Apparently, the changes we have detected in the biofilms of staphylococci under the influence of batumin make them unstable, incapable of persistence and dissemination in the human body.
Another stage of our work was the study of the batumin influence on the processes of biofilm formation by the strain-producer P. batumici (Fig. 2).
Batumin in concentrations of 1 and 10 pg/ml increased biofilm formation by a culture from 0.442 ± 0.126 units of optical density in the control without antibiotic up to 1.539 ± 0.246 and 1.728 ± 0.402, respectively. It was also found that in the planktonic culture of P. batumici B-321 in the presence of 10 pg/ml of batumin, an increase in cell length of the producer by an average of 15% was noted. In control (without batumin), the cell length was 2.34 ± 0.22 x 0.65 ± 0.02 pm; at a concentration of 10 pg/ml of batumen it was 2.69 ± 0.23 x 0.75 ± 0.09 pm. Such an increase in cell length in pseudomonads may be associated with a decrease in the frequency of cell division [21].
In the literature, information is provided on the role of antibiotics, in particular phenazines synthesized by Pseudomonas species, in the biofilms formation by pseudomonads. In this case, phenazine antibiotics are able to change the expression
of genes associated with cell adhesion and the subsequent formation of biofilms [22, 23]. It is possible that the batumin also plays a certain regulatory and functional role in the processes of biofilm formation by P. batumici strain.
Thus, the results of the studies of the batumin influence on biofilm formation processes by P. batumici strain suggest that along with high antimicrobial activity, the positive influence of batumin on the biofilm formation enhances the competitiveness of the producer in relation to other inhabitants of the rhizosphere and attest to the importance of this compound for life-support processes in P. batumici.
Studies of the batumin effect on the formed biofilm of staphylococci showed a significant decrease in its biomass in S. aureus and S. epidermidis at antibiotic concentrations of 0.5 pg/ml, which is only twice as high as the MIC of batumin when it acts on plankton cells. The obtained data for the batumin effect on the formed biofilm of staphylococci shed light on the mechanisms of batumin antimicrobial action, based both on the prevention of the formation of S. aureus and S. epidermidis biofilm, and on the functioning of the biofilm already formed, which makes it possible to consider it as a promising tool in the treatment of infections caused by staphylococci.
REFERENCES
1. Kiprianova E. A., Klochko V. V., Zelena L. B., Churkina L. N, Avdeeva L. V. Pseudomonas batumici sp. nov., the antibiotic-producing
bacteria isolated from soil of the Caucasus Black Sea coast. Microbiol, zh. 2011, 73 (5), 3-8. 2. Klochko V. V., Kiprianova E. A., Churkina L. N., Avdeeva L. V. Antimicrobial spectrum of
atibiotic batumin. Microbiol. zh. 2008, 70 (5), 41-46. (In Russian).
3. Churkina L. N., Kiprianova E.A., Bidnenko S. I., Marchenko K. P., Artysyuk E. I. Antibiotic batumin for diagnostics of staphylococci and treatment of Staphylococcus aureus nasal carriage. Likarska Sprava. 2009, 1-2, 61-67. (In Russian).
4. Ernest E. P., Machi A. S., Karolcik B. A., LaSala P. R, Dietz M. J. Topical adjuvants incompletely remove adherent Staphylococcus aureus from implant materials. J. Orthop. Res. 2017, 15, 1-6. doi: 10.1002/jor.23804.
5. Ha K. R., Psaltis A. J., Butcher A R., Wormald P. J., Tan L. W. In vitro activity of mupirocin on clinical isolates of Staphylococcus aureus and its potential implications in chronic rhinosinusitis. Laryngoscope. 2008, 118, 535540. doi: 10.1097/MLG.0b013e31815bf2e3.
6. Churkina L. N, Vaneechoutte M, Kiprianova E..A., Perunova N. B., Avdeeva L. V., Bukharin O. V. Batumin — a selective inhibitor of staphylococci — reduces biofilm formation in methicillin resistant Staphylococcus aureus. Open J. Med. Microbiol. 2015, 6, 51-59. doi: 10.4236/ojmm.2015.54024.
7. Bukharin O. V., Perunova N. B., Ivanova E. V., Churkina L. N, Avdeeva L. V., Yaroshenko L. V. Morpho-functional changes of Staphylococcus aureus biofilms under the effect batumin. J. Microbiol. Epidemiol. Immunobiol. 2013, 2, 8-12. (In Russian).
8. Nikolaev Yu. A., Plakunov V. K. Biofilm — "City of Microbes" or an Analogue of Multicellular Organisms? Microbiologia. 2007, 76 (2), 149-163. (In Russian).
9. Boubaker I., Abbes I., Abdallah B, Mamlouk H., Mahjoubi F., Kammoun A., Hammami Redjeb S. Evaluation of a cefoxitin disk diffusion test for the routine detection of methicillin-resistant Staphylococcus aureus. Clin. Microbiol. Infect. 2004, 10, 762-765. doi: 10.1111/j.1469-0691.2004.00919.x.
10. Klochko V. V. Biosynthesis and properties of antibiotic batumin. Biotechnol. acta. 2014, 7 (6), 46-50. doi: 10.15407/biotech7.06.046.
11. Wikler M. A., Cockeril F. R., Craig W. A. Performance standards for antimicrobial susceptibility testing; Fifteenths informational supplement. Clin. Labor. Stand. Institute. 2005, 25 (1), 87-151.
12. O'Toole G., Kaplan H., Kolter R. Biofilm formation as microbial development. Ann. Rev. Microbiol. 2000, 54, 49-79. doi: 10.1146/annurev.micro.54.1.49.
13. El Aila N. A., Al Laham N. A., Ayesh B. M. Nasal carriage of methicillin resistant Staphylococcus aureus among health care
workers at Al Shifa hospital in Gaza Strip. BMC Infect Dis. 2017, 17 (1), 28. doi: 10.1186/s12879-016-2139-1.
14. Churkina L. N., Bidnenko S. I., Lutko O. B., Avdeeva L. V., Babenko L. A. Study of the efficiency of antistaphylococcal antibiotic batumin against methicillin resistant strains of staphylococci. Antibiot. Chemother. 2007, 52 (9-10), 19-23. (In Russian).
15. Tetz G. V., Artemenko N. K., Tetz V. V. Effect of DNase and antibiotics on biofilm characteristics. Antimicrob. Agents Chemother. 2009, 53 (3), 1204-1209. doi: 10.1128/AAC.00471-08.
16. Moreno G., Trampuz A., Di Luca M. Synergistic antibiotic activity against planktonic and biof ilmembedded Streptococcus agalactiae, Streptococcus pyogenes and Streptococcus oralis. J. Antimicrob. Chemother. 2017, 72 (11), 30853092. doi: 10.1093/jac/dkx265.
17. Allison K. R., Brynildsen M. P., Collins J. J. Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature. 2011, 473 (7346), 216-220. doi: 10.1038/ nature10069.
18. Churkina L. N., Bidnenko S. I., Avdeeva L. V., Vaneechoutte M., Makushenko A. S., Lut-ko O. B., Oserjanskaja N. M. Characteristics of atypical forms of staphylococci (SCVs), isolated from patients with osteomielitis. An-tibiot. Chemother. 2011, 55 (5-6), 36-40. (In Russian).
19. Tetz V. V., Korobov V. P., Artemenko N. K., Lenikina L. M., Panjkova N. V., Tetz G. V. Extracellular phospholipids of isolated bacterial communities. Biofilms. 2004, 1, 149-155.
20. Lee V. E., O'Neill A. J. Batumin does not exert its antistaphylococcal effect through inhibition of aminoacyl-tRNA synthetaseInt enzymes. J. Antimicrob.Agents. 2016, 49 (1), 121-122.
21. Steinberger R., Allen A., Hansa H., Holden P. Elongation correlates with nutrient deprivation in Pseudomonas aeruginosa — unsaturates biofilms. Microb. Ecol. 2002, 43 (4), 416-423.
22. Chincholkar S., Thomashow L. Microbial Phenazines: Biosynthesis, Agriculture and Health. Springer-Verlag Berlin: Heidelberg. 2013,248 p.
23. Maddula V., Pierson E., Pierson L. Altering the ratio of phenazines in Pseudomonas chlororaphis (aureofaciens) strain 30-84: effects on biofilm formation and pathogen inhibition. J. Bacteriol. 2008, 190. 27592766. doi: 10.1128/JB.01587-07.
ОСОБЛИВОСТ1 ДП АНТИБ1ОТИКА БАТУМ1НУ НА ФОРМУВАННЯ
Б1ОПЛ1ВКИ У Staphylococcus aureus I Pseudomonas batumici
Л. М. Чуркша1 В. В. Клочко1 С. Д. Загородня1 Л. В. Ярошенко1 О. Б. Лютко2
Институт мшробмлогп i вiрусологiï iM. Д. К. Заболотного НАН Украши, Киïв 21нститут ортопедп i травматологiï НАМН Украïни, Кшв
E-mail: [email protected]
Метою роботи було дослщити дiю антибм-тика батумшу на сформовану стафiлококами бiоплiвку, а також на процес бiоплiвкоутво-рення штамом-продуцентом Pseudomonas batumici. Мiнiмальну шпбувальну концен-трацiю (М1К) батумiну встановлено згщно 3i стандартами CLSI 1нституту клiнiчних та ла-бораторних стандармв. Формування бiоплiвки вивчали фотометричним методом 0'Тоо1е за допомогою планшетного фотометра за довжи-ни хвилi 540 нм. З'ясовано, що батумiн проникав у бiоплiвки стафiлококiв i знижував б^-масу сформованоï бiоплiвки у Staphylococcus aureus i S. epidermidis за концентраций антибь отика 0,5 мкг/мл, яка лише у два рази пере-вищуе М1К батумiну за дiï на планктонш кль тини. Змiни бiоплiвки у присутносм батумiну рiзняться у рiзних штамiв стафiлококiв, однак цi вщмшносм не залежать вiд чутливостi або резистентност штамiв до антибiотика.
Уперше встановлено здатнiсть штаму-про-дуцента батумшу до утворення бiоплiвки i стимуляци цього процесу самим антибiотиком у концентращях 1 i 10 мкг/мл. Також вщзна-чено, що у планктоннш культурi P. batumici В-321 за присутностi 10 мкг/мл батумшу дов-жина клiтин продуцента зб^ьшувалась у се-редньому на 15%.
Отримаш данi вiдкривають новi аспекти антимiкробноï дiï батумiну на бiоплiвку стафь лококiв, що полягають як у запоб^анш фор-муванню, так i в шпбуванш вже сформованоï бiоплiвки. Це дае пiдстави розглядати батумш як перспективний засiб лшування стаф^око-кових iнфекцiй.
Ключ-oei слова: батумш, staphylococci, бiоплiвка.
ОСОБЕННОСТИ ДЕЙСТВИЯ АНТИБИОТИКА БАТУМИНА
НА ФОРМИРОВАНИЕ БИОПЛЕНКИ
У Staphylococcus aureus
И Pseudomonas batumici
Л. Н.Чуркина1 В. В. Клочко1 С. Д. Загородняя1 Л. В. Ярошенко1 О. Б. Лютко2
1Институт микробиологии и вирусологии им. Д. К. Заболотного НАН Украины, Киев 2Институт ортопедии и травматологии НАМН Украины, Киев
E-mail: [email protected]
Целью работы было исследование действия антибиотика батумина на сформированную стафилококками биопленку, а также на процесс биопленкообразования штаммом-продуцентом Pseudomonas batumici. Минимальная ингибирующая концентрация (МИК) батуми-на определена в соответствии со стандартами CLSI Института клинических и лабораторных стандартов. Формирование биопленки изучали фотометрическим методом 0'Тоо1е с помощью планшетного фотометра при длине волны 540 нм. Установлено, что батумин проникал в биопленки стафилококков и снижал биомассу сформированной биопленки у Staphylococcus aureus и S. epidermidis при концентрации антибиотика 0,5 мкг/мл, которая лишь в два раза превышала МИК батумина при действии на планктонные клетки. Изменения биопленки в присутствии батумина различаются у разных штаммов стафилококков, однако эти различия не зависят от чувствительности или резистентности штаммов к антибиотику.
Впервые установлена способность штамма-продуцента батумина к образованию биопленки и стимуляции этого процесса самим антибиотиком в концентрациях 1 и 10 мкг/мл. Также было отмечено, что в планктонной культуре P. batumici В-321 в присутствии 10 мкг/мл ба-тумина длина клеток продуцента увеличилась в среднем на 15%.
Полученные данные открывают новые аспекты антимикробного действия батумина на биопленку стафилококков, которые состоят как в предотвращении формирования биопленки, так и в ингибировании уже сформировавшейся биопленки. Это дает основания рассматривать батумин как перспективное средство лечения стафилококковых инфекций.
Ключевые слова: батумин, staphylococci, биопленка.
